Citigroup
BLFS icon

Citigroup’s BioLife Solutions BLFS Stock Holding History

Citigroup’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,000
Closed -$228K – 5657
2025
Q1 		$228K Buy
+10,000
New +$263K ﹤0.01% 4128

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Citigroup's BLFS Position: Q2 2026 in Review

Citigroup increased its BioLife Solutions (BLFS) stake by 6.9% in Q2 2026, buying an estimated $34.5K and bringing the position to 22,859 shares worth $646K. The position accounts for ﹤0.01% of the portfolio, ranked #3761.

Citigroup first reported a position in BLFS in Q3 2014 and has held it in 34 quarters since. The position peaked at $1.78M in Q3 2025. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Citigroup held 22,859 shares of BioLife Solutions worth $646K as of Q2 2026.
  • Citigroup bought 1,475 BioLife Solutions shares in Q2 2026, an estimated $34.5K.
  • BioLife Solutions made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #3761 holding.
  • Citigroup first reported a position in BioLife Solutions in Q3 2014 and has held it in 34 quarters since.
  • Citigroup's BioLife Solutions position peaked at $1.78M in Q3 2025.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.